Clinical Trial Update: F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery [NA]

View source ↗

Summary

A completed clinical trial evaluating F18 fluciclovine PET/CT to measure tumor volume and response to radiation therapy in glioblastoma patients undergoing surg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Axumin (fluciclovine F-18)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma | NA | Status: COMPLETED